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September 2011922 Abstracts75% of program directors support development of a national policy, and
81% would incorporate it into their program.
Conclusions: There is compelling interest to establish radiation safety
guidelines for the pregnant trainee or vascular surgeon. Consideration
should be given at the Society leadership level to develop and support
radiation safety guidelines for all vascular surgeons.
Antibiotic-Loaded Polymethylmethacrylate Beads for the Treatment of
Extracavitary Prosthetic Vascular Graft Infections: Revisited
Patrick A. Stone, MD, Daniel Dearing, Ali Aburahma, West Virginia Uni-
versity, Charleston, WV
Objective(s): This study was conducted to further assess the efficacy of
antibiotic-loaded polymethylmethacrylate (PMMA) beads in the treatment
of lower extremity prosthetic arterial bypass infections.
Methods: This was a retrospective review of all patients with lower
extremity vascular surgery site (VSS) infections involving lower extremity
bypasses treated with antibiotic-loaded PMMA beads and culture-specific
parenteral antibiotics during a 4.5-year period. Patient demographics, co-
morbidities, site of initial graft infection, initial and additional surgical
debridements, wound culture results, type of antibiotic beads implanted,
and graft treatment strategy were evaluated. Primary outcome measures
included mortality, recurrent infection, and limb salvage.
Results: A total of 44 lower extremity VSS infections developed in 42
patients, with a treatment algorithm including the use of antibiotic-impreg-
nated PMMA beads. These included 12 aortoiliac-femoral bypasses, 23
infrainguinal bypasses, and 6 extra-anatomic bypasses, and 3 patients with
combined inflow/outflow bypass procedures with groin infection. Cultures
isolated 60 pathogens, (35 gram-positive, 23 gram-negative) with methicil-
lin-resistant Staphylococcus aureus (MRSA) cultured from 11 wounds
(18.3%), and 4 (8.9%) patients had no growth despite clinical signs of
infections. Vancomycin beads were initially placed in all patients, with
selective addition of gentamycin to the PMMA beads. Repeat VSS explora-
tion and culture results led to an average of 1.3 bead replacements before
definitive treatment. Treatment strategy included graft preservation in 28
patients (63.6%), partial graft excision with in situ replacement in 10
(22.7%), and total graft excision in 6 (13.6%). Sartorius muscle flap was
performed in 15 patients (34.1%). Perioperative mortality was 2.4%. At a
median follow-up of 22 months, the limb salvage rate was 79% and the
recurrent infection rate was 9.0%.
Conclusions: Antibiotic-loaded PMMA beads serve as adjunct in the
management of VSS infections and expand treatment options for graft
preservation or in situ reconstructions, with low rates of recurrent infections.
Further experience with this adjunct may help elucidate its role in the
management of this complicated problem.
Concurrent Prophylactic Placement of Inferior Vena Cava Filter in
Gastric Bypass and Adjustable Banding Operations: An Analysis of the
Bariatric Outcomes Longitudinal Database (BOLD)
Wei Li, MD, MPH1 Piotr Gorecki, MD,2 Robert Autin, MD,2 William
Briggs, PhD,2 Elie Semaan, MD,2 Massrcus D’Ayala, MD,2 1New York
Methodist Hospital, Brooklyn, NY; 2New YorkMethodist Hospital, Brook-
lyn, NY
Objective(s): Postoperative pulmonary embolism (PE) is a leading
cause of death after bariatric surgery. The concurrent prophylactic place-
ment of an inferior vena cava filter (CPPOIVCF) in patients undergoing
bariatric operations remains controversial. This study used the Bariatric
Outcomes Longitudinal Database (BOLD) to determine associated charac-
ters and outcomes of CPPOIVCF for patients undergoing gastric bypass
(GB) and adjustable banding (AB) surgeries.
Methods: We analyzed BOLD, a prospective database of bariatric
surgery patient information. GB and AB operations were categorized into
open and laparoscopic approaches. Univariate logistic regressions were used
to compare between non-CPPOIVCF and CPPOIVCF groups.
Results: We identified 322 CPPOIVCF (0.33%) from 97218 GB and
AB operations performed between 2007 and 2010. Significant differences
were identified in the categories of male sex (21.1% vs 31.4%; P  .001),
preoperative body mass index (44.5  6.6 vs 45.3  7 kg/m2, P  .001),
and African American race (10.5% vs 18%, P  .001) between non-CP-
POIVCF and CPPOIVCF groups. The CPPOIVCF group had more pa-
tients with previous nonbariatric surgery (50% vs 43.6%, P  .02), a history
of venous thromboembolism (21.4% vs 3.1%, P  .001), impairment of
functional status (7.8% vs 3.1%, P .001), lower extremity edema (47.2% vs
27.1%, P  .001), obesity hypoventilation syndrome (7.1% vs 2.1%, P 
.001), obstructive sleep apnea syndrome (58.1% vs 43.3%, P  .001), and
pulmonary hypertension (13% vs 4.1%, P  .001). Patients in the CP-
POIVCF group were more likely to receive GB than AB (77% vs 58.1%, P
.001) and an open surgical approach (21.4% vs 4.8%, P  .001). Operative
duration was longer in the CPPOIVCF group (119  67 vs 89  52
minutes, P .001). The CPPOIVCF group also had a longer hospital LOS
(3 2 vs 2 6 days, P .048), was associated with higher incidence of deep
n
lein thrombosis (0.93% vs 0.12%, P .001), and a higher mortality (0.31%
s 0.03%, P  .003) from PE and indeterminate causes.
Conclusions:CPPOIVCFwas associated with specific clinical features,
ncreased health care resource utilization, and a higher mortality in patients
ndergoing bariatric operations. This study was unable to establish an
utcome benefit for CPPOIVCF.
“Fall-Back” Technique for Difficult Inferior Vena Cava Filter Re-
rieval
aul J. Foley, MD, Derek P. Nathan, MD, Grace J. Wang, MD, Edward Y.
oo, MD, S.W. Stavropolous, MD, Richard D. Shlansky-Goldberg, MD,
onald M. Fairman, MD, Benjamin M. Jackson, MD, Hospital of the
niversity of Pennsylvania, Philadelphia, Pa
Objective(s): This study describes the results of a novel technique for
nferior vena cava filter (IVCF) retrieval when the retrieval hook cannot be
nared, for example, because it is embedded in the caval wall.
Methods: A retrospective review of all patients undergoing at-
empted IVCF retrieval by a single surgeon between March 2009 and
arch 2011 was undertaken. After December 2009, in cases where the
ook could not be snared, an 18F 85-cm sheath was inserted into the
nternal jugular vein and a Bentson wire and snare were advanced across
eparate interstices of the filter. The resulting “lasso” was pulled up
elow the collar at the top of the filter, and the filter collapsed into the
heath, as in the Fig.
Results: Over 24 months, 28 patients (17 women) underwent at-
empted retrieval of Günther Tulip® filters. Patients were 44 14 years old.
ilters were placed for venous thromboembolism with contraindication to
nticoagulation in 7 patients and prophylactically in 21. Of the prophylactic
ases, 15 (71%) were placed before planned bariatric surgery. Before Decem-
er 2009, the success rate was 86% (6 of 7): the retrieval hook of one filter
ould not be snared and appeared to be embedded in the wall of the cava.
fter adoption of the novel technique, the success rate was 95% (20 of 21):
ne patient refused further attempts at central venous catheterization after
ultiple unsuccessful attempts. Durations of filter implantation were 4.5 
.3 months for filters retrieved conventionally by snaring the hook and 12.8
10.7 months (P  .02) for 10 that were retrieved using the new
echnique. All patients were discharged on the day of the procedure. The
atient in whom the retrieval hook could not be snared before December
009 refused another attempt at retrieval.
Conclusions: A novel method of IVCF retrieval was successful in every
nstance in which it was attempted. It was associated with no morbidity
espite the customary use of an 18F sheath in the internal jugular vein. The
pproach constitutes an appropriate “fall-back” technique when the retrieval
ook of a removable IVCF cannot be snared.
istal Bypass in the Endovascular-First Era: Is There Still a Need for
pen Surgery?
. Clement Darling, III, MD, Manish Mehta, MD, MPH, Sean P. Roddy,
D, Benjamin B. Chang, MD, Paul B. Kreienberg, MD, Philip S.K. Paty,
D, Kathleen J. Ozsvath, MD, John Taggert, MD, Yaron Sternbach, MD,
hiraj M. Shah, MD Albany Medical College, Albany, NY
Objective(s): Like most we have adopted an aggressive endovascular
pproach and reserve bypass surgery only for lesions that cannot be crossed
r are deemed anatomically unsuitable for catheter-based therapy. This
eport details our results with open infrainguinal reconstruction for patients
ho are not suitable for endovascular intervention.
Methods: All patients presenting with claudication or critical limb
schemia (CLI), including rest pain, nonhealing ulcer, and gangrene, were
rospectively entered into our vascular registry. Inflow, outflow, conduit,
evisions, morbidity, and death were measured and evaluated. During this
ame period, patients treated with endovascular methods were also evalu-
ted.
Results: From 2008 to 2010, 1316 bypasses were performed: 231 for
laudication and 1085 for CLI (35% for rest pain, 39% for nonhealing ulcer,
nd 26% for gangrene). The 30-day operative mortality for the total group
as 31 (2.86%). There was no operative mortality for patients presenting
ith claudication and 2.86% (n 31) for those patients presenting for CLI.
mmediate limb loss was 0 in the claudicant patients, but occurred in 20
1.84%) in the CLI patients. At 30 days, 1 year, and 2 years, respectively,
imb preservation was 100%: 99.6% in the claudication group, and 97%, 94%,
nd 93%, respectively, for the CLI group. In the endovascular group there
as no periprocedural deaths, 15% required secondary procedures, 14% for
laudicants and 17% for CLI (P  NS).
Conclusions: A balanced approach of distal reconstruction is still
ecessary to promote optimal mortality, morbidity, short-term patency, and
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Volume 54, Number 3 Abstracts 923Long-term Anatomic and Functional Outcomes of Pharmacomechani-
cal Thrombolysis of Iliofemoral Deep Vein Thrombosis
Eric S. Hager, MD, Luke Marone, MD, Robert Rhee, MD, Jae Cho, MD,
Michel Makaroun,MD, Rabih Chaer, MDUniversity of PittsburghMedical
Center, Pittsburgh, Pa
Objective(s): The long term effect of pharmacomechanical thrombol-
ysis (PMT) on venous patency and valve function are not known. Our
objective was to examine the long-term anatomic and functional outcomes
of PMT for iliofemoral deep vein thrombosis (IFDVT).
Methods: A retrospective review of all patients with symptomatic DVT
treated between 2006 and 2010 with PMTwas performed. All patients were
treated by a combination of local tissue plasminogen activator (tPA) with the
Angio-jet or Trellis® device. Catheter-directed thrombolysis (CDT) was
used selectively for residual thrombus.
Results:Ninety limbs were treated in 69 patients whowere amean age of
50 years (range 18-83). Patients presented with pain (67%) swelling (17%) and
phlegmasia (6%) averaging 12 days in duration (range 1-48 days); with a mean
follow-up of 22 months (range, 3-39 months; Table). All patients were treated
with PMT, but 49 (71%) required additional CDT. The iliac vein was stented in
42% of patients. Successful lysis (50% lysis) was achieved in 92%, with symp-
tom resolution in 98% of patients initially and in 94% at follow-up. There were
two DVT recurrences necessitating reintervention at 5 and 20 days, both
secondary to premature discontinuation of anticoagulation. The averageVillalta
score at the latest follow-up was 3, with 74% of patients having preserved valve
function by duplex imaging. Mild persistent/chronic clot was seen in 32% on
follow-up duplex imaging, but the overall vein patency was 91% with no deep
venous reflux. Two asymptomatic iliac stent thromboses did not require rein-
tervention. Patients treated with isolated single setting PMT (group A, n 20)
had similar long termoutcomes as those needing additionalCDT (groupB, n
49), with equally sustained clinical improvement and an average Villalta score of
3 and an average CEAP score of 1 (P  NS) in both groups. The overall vein
patency rates were 90% vs 92%, despite a higher percentage ofminor persistent/
chronic clot in group A (40%) vs group B (24%) on duplex follow-up imaging.
Conclusions: Isolated single setting PMT and PMT with CDT are
equally effective and durable for the treatment of iliofemoral DVT, with low
rates of recurrence, and good long term physiologic and functional outcomes.arly Experience With Mechanical Chemical Ablation of the Great
aphenous Vein
ennifer Heller; MD, Johns Hopkins Bayview Medical Center, Baltimore, Md
Objective(s): Mechanical chemical ablation (MECA) of the super-
cial axial venous system has recently been introduced as a novel device
hat eliminates potential nerve injury and is tumescence free. This study
xamined early perioperative and postoperative outcomes using MECA.
Methods: Fifteen patients (14 women, 1 man) with symptomatic
uperficial venous insufficiency were consecutively invited to undergo
ECA. All patients demonstrated refractory symptoms despite conservative
anagement and significant reflux of the great saphenous vein (GSV) by
enous reflux examination. Patients were a mean age of 52 years (range
3-67 years). MECA was performed using the ClariVein® device with 1.5%
otradecol sclerosant. Intravenous conscious sedation was administered.
he mean venous clinical severity score (VCSS) was 8 (range, 6-9). Clinical
lassification using the CEAP descriptors revealed 15 patients at C2, 3 at C3,
nd 3 at C4. All patients underwent MECA of the GSV. No small saphenous
eins were treated. Twelve axial veins were accessed at the below knee
osition (2 at the ankle) and one above the knee. Concomitant stab
hlebectomies were performed in 11 patients.
Results: At the 48-hour follow-up duplex examination, 13 GSVs
emonstrated no flow, 2 exhibited partial flow, and 1 remained widely
atent. Postprocedural duplex studies revealed normal deep venous systems
n all patients. All 15 patients demonstrated improved VCSS scores. There
ere no postoperative complications.
Conclusions:Mechanical chemical ablation of the great saphenous vein is
promising therapeutic modality. Further evaluation is needed to evaluate
ong-term success and comparison with accepted endovenous techniques.
omparative Analysis of Femoropopliteal Versus Tibial Lesion Char-
cteristics that Predict Endovascular Therapy Success
n-Kyong Kim, MD, Natalia Egorova, PhD, Sikandar Z. Khan, MD, An-
rew J. Melzer, MD, James F. McKinsey, MD, New York-Presbyterian
ospital, Columbia University, New York, NY
Objective(s): Critical lesion characteristics that predict loss of patency
fter endovascular therapy (EVT) is poorly defined and has not been
pecified for respective lesion locations. This study differentiates the inde-
endent factors for femoropopliteal and tibial lesions and their comparative
mpact on patency.
Methods: All EVT for femoropopliteal and tibial artery lesions from
005 to 2009 at our institution were reviewed. Patency was evaluated by
aplan-Meier analysis and Cox proportional hazards regression.
Results: A total of 1776 discrete femoropopliteal or tibial lesions, or
oth, in 818 patients were treated. There were 1329 femoropopliteal lesions
n 675 patients (56.4%male; age, 72.4) and 447 tibial lesions in 275 patients
61.1% male; age, 71.9), and 17.5% of femoropopliteal lesions had concom-
tantly treated tibial lesion, and 45.9% of tibial presented with a femoropop-
iteal lesion. Overall 1-year primary patency rates were 61.5% for femoro-
opliteal and 60.0% for tibial lesions. Critical factors determining loss of
atency varied greatly between the lesion types: lesion calcification, which
ad a large effect on tibial patency, had no effect on femoropopliteal patency
P .0001). Multivariate Cox regression analysis revealed that independent
isk factors for loss of patency of femoropopliteal lesions were diabetes
hazard ratio [HR], 1.29; P .006), congestive heart failure (HR, 1.37; P
002), lesion length100 mm (HR, 1.64; P .0001), stenosis 80% to 99%
HR, 1.43; P  .003), and chronic occlusion (HR, 1.73; P  .0001). In
ontrast, factors for tibial lesions were diabetes (HR, 1.78; P  .041) and
alcification (HR, 2.21; P  .0001; Table).
Conclusions: Factors that impact loss of patency after EVT differ for
emoropopliteal and tibial lesions, especially in lesion characteristics. Femoro-
opliteal patency ismost affected by the lesion length and the degree of stenosis,
hereas tibial by the presence of calcification. These differences in factors point
o a need for a location-specific lesion severity score to allow for comparison of
esions and the probability of successful endovascular intervention.
able. Independent factors that predict loss of patency
actor HR (95% CI) P
emoropopliteal lesions
Diabetes 1.29 (1.023-1.627) .0311
Congestive heart failure 1.367 (1.058-1.768) .0169
Length 100 mm 1.649 (1.351-2.012) .0001
80-90% stenosis 1.429 (1.128-1.811) .0031
100% stenosis 1.733 (1.327-2.263) .0001
ibial lesions
Diabetes 1.778 (1.023-3.090) .0413
Calcification 2.207 (1.509-3.229) .0001
